- Home
- Products
- Customized ADCs
- FN1
- Anti-FN1-CemCH2-SH ADC
Anti-FN1-CemCH2-SH ADC (CAT#: ADC-W-575)
This ADC product is comprised of an anti-FN1 monoclonal antibody (clone F8) conjugated via a linker to CemCH2-SH.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- F8
- Name
- FN1
- Alternative Names
- FN1; fibronectin 1; FN; CIG; FNZ; MSF; ED-B; FINC; GFND; LETS; GFND2; fibronectin; cold-insoluble globulin; migration-stimulating factor;
- Target Entrez Gene ID
- 2335
- Target UniProt ID
- P02751
- Overview
- This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants. However, the full-length nature of some variants has not been determined.
- Overview
- Anti-FN1 Antibody, clone # F8
- Clone #
- F8
- Name
- disulfide linker
- Name
- CemCH2-SH
- Description
- Cemadotin is a synthetic analogue of dolastatin 15 with potent antiproliferative and preclinical antitumor activity.The dolastatins are a class of naturally occurring cytotoxic peptides which function by inhibiting microtubule assembly and tubulin polymerization.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ERBB2 (Margetuximab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1109)
- Anti-Fibrin II-beta chain (Biciromab)-SMCC-DM1 ADC (CAT#: ADC-W-1994)
- Anti-MS4A1 (Ocrelizumab)-SPDB-DM4 ADC (CAT#: ADC-W-1575)
- Anti-CD74-SMCC-Dox ADC (CAT#: ADC-W-479)
- Anti-CCL11 (Bertilimumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-750)
- Anti-IL1B (Gevokizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1332)
- Anti-CEACAM6 (Sulesomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-979)
- Anti-CD28 (lumretuzumab)-SPDB-DM4 ADC (CAT#: ADC-W-2277)
- Anti-EGFR (Matuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1039)
- Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2363)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-575. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-507 | Anti-FN1-DM1-SH ADC | disulfide linkers | DM1-SH(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine-SH) |
| ADC-W-508 | Anti-FN1-SIP-DM1-SH ADC | disulfide linkers | DM1-SH(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine-SH) |
| ADC-W-1156 | Anti-FN1 (Radretumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-1155 | Anti-FN1 (Radretumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-1154 | Anti-FN1 (Radretumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
